NIH-funded research NIH-funded research

Understanding how a specific receptor affects gum disease and bone loss

Official title: Mechanisms of peroxisome proliferator-activated receptor-alpha regulation in peridontitis

Funded at Ada Forsyth Institute, INC. · NIH-10915090 · Data updated 2026-11-12

This study is looking at how a specific protein in your body might help reduce inflammation and bone loss in gum disease, which could lead to new treatments that improve your gum health and protect your bones.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionAda Forsyth Institute, INC.
NIH-funded
Lab location1 site (Cambridge, United States)
Project startSeptember 8, 2023
Project endSeptember 7, 2025
Funding year2023
Award (this year)$497,500
NIH project number1R56DE032325-01A1
Project IDNIH-10915090 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from periodontal disease or those at risk of developing it.

Less likely to help

Patients without periodontal disease or those with conditions unrelated to gum health may not benefit from this research.

What this research studies

This research investigates the role of peroxisome proliferator-activated receptor-alpha (PPARα) in periodontal disease, focusing on its impact on inflammation and bone resorption. The study aims to understand how activating PPARα can reduce inflammation and bone loss associated with periodontitis by examining its effects on immune cells and signaling pathways. Patients may benefit from insights into new treatments that target this receptor to improve gum health and prevent bone damage. The research involves laboratory experiments using gingival cells and animal models to explore these mechanisms.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for managing periodontal disease and preventing associated bone loss.

How similar studies have gone: Previous research has shown promising results in targeting similar pathways for treating inflammatory conditions, suggesting potential for success in this area.

Where this research is happening

  • Ada Forsyth Institute, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Hu, Yang — Ada Forsyth Institute, INC.
  • Study coordinator: Hu, Yang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.